Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

China Pharma Holdings Return on Tangible Equity 2010-2023 | CPHI

Current and historical return on tangible equity values for China Pharma Holdings (CPHI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
China Pharma Holdings Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $-0.00B $0.00B -85.71%
2023-09-30 $-0.00B $0.00B -100.00%
2023-06-30 $-0.00B $0.00B -109.09%
2023-03-31 $-0.00B $0.00B -100.00%
2022-12-31 $-0.00B $0.00B -114.29%
2022-09-30 $-0.00B $0.00B -88.89%
2022-06-30 $-0.00B $0.00B -72.73%
2022-03-31 $-0.00B $0.01B -66.67%
2021-12-31 $-0.00B $0.01B -61.54%
2021-09-30 $-0.00B $0.01B -57.14%
2021-06-30 $-0.00B $0.01B -55.17%
2021-03-31 $-0.00B $0.01B -38.71%
2020-12-31 $-0.00B $0.01B -37.50%
2020-09-30 $-0.02B $0.01B -254.55%
2020-06-30 $-0.02B $0.01B -161.54%
2020-03-31 $-0.02B $0.01B -120.55%
2019-12-31 $-0.02B $0.01B -88.42%
2019-09-30 $-0.01B $0.03B -34.48%
2019-06-30 $-0.01B $0.03B -34.92%
2019-03-31 $-0.01B $0.03B -31.88%
2018-12-31 $-0.01B $0.03B -28.95%
2018-09-30 $-0.02B $0.04B -41.21%
2018-06-30 $-0.02B $0.04B -36.76%
2018-03-31 $-0.02B $0.04B -35.82%
2017-12-31 $-0.02B $0.04B -35.35%
2017-09-30 $-0.01B $0.06B -13.91%
2017-06-30 $-0.01B $0.06B -13.50%
2017-03-31 $-0.01B $0.06B -13.01%
2016-12-31 $-0.01B $0.06B -13.90%
2016-09-30 $-0.02B $0.06B -30.77%
2016-06-30 $-0.02B $0.07B -22.15%
2016-03-31 $-0.01B $0.07B -16.40%
2015-12-31 $-0.02B $0.07B -18.02%
2015-09-30 $-0.02B $0.08B -25.00%
2015-06-30 $-0.03B $0.09B -32.21%
2015-03-31 $-0.04B $0.09B -40.00%
2014-12-31 $-0.04B $0.09B -34.59%
2014-09-30 $-0.03B $0.11B -22.00%
2014-06-30 $-0.02B $0.12B -17.73%
2014-03-31 $-0.02B $0.13B -13.28%
2013-12-31 $-0.02B $0.13B -13.62%
2013-09-30 $-0.01B $0.14B -6.98%
2013-06-30 $-0.01B $0.14B -4.84%
2013-03-31 $-0.00B $0.14B -0.69%
2012-12-31 $0.01B $0.15B 3.44%
2012-09-30 $0.01B $0.15B 6.97%
2012-06-30 $0.01B $0.15B 9.98%
2012-03-31 $0.02B $0.14B 13.18%
2011-12-31 $0.02B $0.14B 16.24%
2011-09-30 $0.02B $0.13B 19.86%
2011-06-30 $0.02B $0.10B 23.41%
2011-03-31 $0.02B $0.10B 25.74%
2010-12-31 $0.02B $0.11B 27.12%
2010-09-30 $0.02B $0.08B 25.89%
2010-06-30 $0.02B $0.08B 28.47%
2010-03-31 $0.02B $0.08B 26.67%
2009-12-31 $0.02B $0.07B 25.99%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.004B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.482B 5.59
Dr Reddy's Laboratories (RDY) India $12.441B 19.67
Aspen Pharmacare (APNHY) South Africa $5.038B 0.00
BridgeBio Pharma (BBIO) United States $4.656B 0.00
Bausch Health Cos (BHC) Canada $3.183B 2.48
Amphastar Pharmaceuticals (AMPH) United States $2.009B 13.75
Supernus Pharmaceuticals (SUPN) United States $1.646B 0.00
Taysha Gene Therapies (TSHA) United States $0.447B 0.00
Generation Bio (GBIO) United States $0.193B 0.00
Assembly Biosciences (ASMB) United States $0.069B 0.00
Personalis (PSNL) United States $0.064B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.025B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00